We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$53M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$26.7M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$23.7M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$19.5M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15M

Sector Composition

Rank Sector Weight
1 Technology 26.99%
2 Healthcare 10.86%
3 Consumer Discretionary 10.71%
4 Financials 8.62%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BXP icon
1251
Boston Properties
BXP
$10.8B
$439K 0.01%
5,852
-6,093
-51% -$518K
DNLI icon
1252
Denali Therapeutics
DNLI
$4B
$437K 0.01%
14,216
+3,700
+35% +$120K
MLAB icon
1253
Mesa Laboratories
MLAB
$569M
$436K 0.01%
3,094
+2,866
+1,257% +$523K
MTDR icon
1254
Matador Resources
MTDR
$6.49B
$436K 0.01%
8,916
-11,100
-55% -$599K
TDV icon
1255
ProShares S&P Technology Dividend Aristocrats ETF
TDV
$280M
$435K 0.01%
8,594
-554
-6% -$31.5K
EHC icon
1256
Encompass Health
EHC
$12.5B
$434K 0.01%
9,603
+519
+6% +$26K
MZTI
1257
The Marzetti Company
MZTI
$3.13B
$433K 0.01%
2,880
+1,684
+141% +$250K
SAA icon
1258
ProShares Ulta SmallCap600
SAA
$30.1M
$433K 0.01%
23,975
+2,489
+12% +$56.1K
PRKS icon
1259
United Parks & Resorts
PRKS
$2.07B
$433K 0.01%
9,518
+985
+12% +$49K
CHGG icon
1260
Chegg
CHGG
$94.8M
$432K 0.01%
20,503
-872
-4% -$18.1K
H icon
1261
Hyatt Hotels
H
$16B
$432K 0.01%
5,330
+3,439
+182% +$292K
SAGE
1262
DELISTED
Sage Therapeutics
SAGE
$432K 0.01%
11,019
-10,513
-49% -$406K
FIGS icon
1263
FIGS
FIGS
$2.39B
$430K 0.01%
52,070
+27,672
+113% +$294K
WMS icon
1264
Advanced Drainage Systems
WMS
$10.7B
$430K 0.01%
3,458
+2,159
+166% +$269K
DRV icon
1265
Direxion Daily Real Estate Bear 3X ETF
DRV
$26.7M
$429K 0.01%
6,356
+5,791
+1,025% +$268K
LABU icon
1266
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$637M
$429K 0.01%
3,059
+2,737
+850% +$502K
HCC icon
1267
Warrior Met Coal
HCC
$5.04B
$428K 0.01%
15,056
+13,153
+691% +$405K
ICLR icon
1268
Icon
ICLR
$12.8B
$428K 0.01%
2,328
-441
-16% -$96K
WSM icon
1269
Williams-Sonoma
WSM
$29.5B
$425K 0.01%
7,202
-5,244
-42% -$372K
BC icon
1270
Brunswick
BC
$5.21B
$424K 0.01%
6,484
+2,193
+51% +$165K
NJR icon
1271
New Jersey Resources
NJR
$5.45B
$424K 0.01%
10,965
+4,426
+68% +$197K
TCBI icon
1272
Texas Capital Bancshares
TCBI
$4.32B
$424K 0.01%
7,187
+312
+5% +$18.5K
MRTX
1273
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$424K 0.01%
6,075
-8,721
-59% -$645K
GEVO icon
1274
Gevo
GEVO
$382M
$423K 0.01%
185,500
+143,036
+337% +$399K
SAIA icon
1275
Saia
SAIA
$9.49B
$423K 0.01%
2,226
-1,423
-39% -$302K
49 50
51
52 53

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.